• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • Manage Studies
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

J&J Covid-19 Vaccine Blood-Clot Cases Could Stir Vaccine Hesitancy

by William Jester | May 6, 2021 | Community, Covid, News

Blood-clot issues surrounding Johnson & Johnson’s Covid-19 vaccine could complicate the U.S. mass vaccination campaign, deterring people who are already hesitant and giving room for misinformation to spread, health experts said. Concerns that the blood-clot issue...

Rutgers Family Medicine and Community Health Expert Co-authors National Academies Report on Primary Care

by William Jester | May 5, 2021 | Community, News

The National Academies of Sciences, Engineering and Medicine has released a  report that evaluated the state of primary care today to develop a plan to strengthen primary care services in the United States, especially in underserved communities. The...

Could the COVID-19 vaccines impact menstruation? Experts discuss

by William Jester | May 5, 2021 | Community, Covid, News

After Katherine Lee received her COVID-19 vaccine, she and a colleague chatted about their side effects. Because they worked in a medical school, they received their shots early and felt this might be a good opportunity to understand the experience. While they...

NJ ACTS Special Populations Core 2021 Webinar Series on May 11th

by Pamela Dahlen | May 5, 2021 | News

Join the Special Populations core as Donald (Rusty) Reeves, MD Director of Psychiatry, Rutgers-University Correctional Health Care and Peter Treitler, MSW Research Specialist, Rutgers Center for Health Services Research present “Medications for Opioid Use...
Rutgers Begins COVID-19 Prevalence Study in Newark

Rutgers Begins COVID-19 Prevalence Study in Newark

by William Jester | May 4, 2021 | Community, Covid, News

Rutgers will help determine the prevalence of the coronavirus in Newark, one of the cities hardest hit by the pandemic, as part of the National Institutes of Health COVID-19 Prevention Network (CoVPN) response to the deadly global outbreak. The university is one of 26...
« Older Entries
Next Entries »

Recent Posts

  • Rutgers–Newark Scientists Use RNA Nanotechnology to Program Living Cells, Opening New Path for Cancer Cure.
  • Rutgers Advances Non-Opioid Solutions for Chronic Pain.
  • How Gender Bias Influences Math Education.
  • Join NJ ACTS for Special Populations Seminar on 4/28 at 12pm
  • Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th

Archives

  • 2026
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,478)
  • Covid (999)
  • CTO Events (6)
  • News (3,143)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.